tinuous photoelectric recording of the dye curves was obtained by means of a Gilford Model 103 densitometer. 8 The curves were calibrated by a previously described volumetric technique, 0 and calculations were made according to the Stewart-Hamilton formula. 10 The dye was injected into an antecubital vein in all except two subjects. In the latter subjects the dye was injected into the superior vena cava, and the "included volume 1 ' between the superior vena cava and points temporally equidistant as the brachial artery sampling site were calculated using the Hamilton formula. 3 ' Braehial arterial pressure was recorded and electrically integrated for the mean value before and after each cardiac output study using a Sta.tham P23D transducer and Sanborn oscillograph. Heart rate was obtained from electrocardiographic tracings. Oxygen consumption was determined during a three-minute period at the time of each output study. The subject breathed room air from a Tissot apparatus, discharging expired air into a Douglas bag. Carbon dioxide and oxygen of both inspired and expired gas were analyzed by use of the Scholander apparatus.
The subjects rested quietly in the supine position for at least 20 minutes after introduction of arterial and venous needles before the study was begun. Paired determinations of cardiac output, arterial pressure, and oxygen consumption were obtained during an infusion of normal saline solution and were repeated after at least 12 minutes of constant infusion with dopamine. Tn three subjects, studies were also obtained after discontinuation of the dopamine infusion.
Tn the patients undergoing diagnostic cardiac on theterizations, left a trial pressure was obtained at the time of cardiac output determinations by means of the Ross transseptal technie. 12 Results of the diagnostic studies in these two patients were within normal limits. Cardiac output determinations were carried out by the dye-dilution technique, as described above, except that the dye was injected into the left atrium.
The infusion rates of dopamine and J-norepinephrine (Levophed) producing equivalent systolic blood pressure increments during a 15minute infusion period were calculated in a separate series of experiments with normal subjects. Blood pressure in these studies was obtained by n. standard sphygmomanometer at 2-minute intervals. Several infusion rates were used for each Minine in each subject and dose-response curves were plotted. The infusion r.ates producing a 25 8. mm. Hg systolic pressure increment were then estimated from the dose-response curves.
Cardiovascular Effects of Dopamine in
The effect of dopamiue on blood glucose levels was determined during similar dopamine infusions. Samples were obtained 30 minutes and immediately before start of the infusion and after 5, 15, and 30 minutes of constant infusion. Glucose was analyzed by the method of Hoffman 13 as modified for use with the Autoanalyzer (Technicon Instrument Corporation.).
Results

HEMODYNAMIC STUDIES
Studies in six normal subjects indicated that the predominant effect of dopamine infusion is an increase in cardiac output. The data are shown in table 1 and figure 1. Cardiac output and stroke volume increased in each subject. Comparison of the paired control values with the two values obtained during dopamine infusion demonstrated that the increments in cardiac output and stroke volume are highly significant (P<0.01). Calculated peripheral resistance decreased in five of the subjects and did not change in the other. Heart rate changes were not stastistically significant, varying from an increase of 13 beats/min. to a decrease of 12 beats/ min. Calculated atrioventricular oxygen difference decreased in five of the six subjects and did not change in the other, indicating that the increase in blood flow was not accompanied by a proportional increase in total body oxygen demand. Measurements of the "included volume" between the superior vena cava and points temporally equidistant as the brachial artery sampling site obtained in two of the subjects indicated that this "volume" decreased slightly in both subjects.
The increase in stroke volume produced by dopamine resulted in greater systolic than diastolic blood pressure increments. This effect is illusti'ated in figure 2 which shows the changes in braehial artery blood pressure contours produced by dopamine. The effects of a norepinephrine infusion shown in figure 2 , are characteristically different. The greater rise in diastolic pressure, the pronounced bradycardia, and the gradual rise and fall of the pulse contour with norepinephrine differ distinctively from the effects of dopamine. Similar contrasting effects on brachial artery pulse pressure contours were observed in four other subjects given dopamine and norepinephrine. As described previously, 7 the effects of dopamine on systolic blood pressure became evident within 2 to 4 minutes after starting the infusion. The duration of action after discontinuation of the infusion varied with the different subjects, but, in most of them, the blood pressure had returned to control values within 10 minutes. Hemodynamic measurements obtained 21 to 41 minutes after discontinuation of the infusion in three subjects. (A.R., G.S., CM.) are shown in table 1.
Left atrial pressure did not change in the two patients in whom dopamine was administered during cardiac catheterization. Cardiac output, on the other hand, was increased as in the normal subjects. In one patient, the infusion of dopamine at a rate of 5.8 /xg./Kg./min. resulted in a 60 per cent increase in cardiac output. In the other patient, dopamine was infused at a rate of 6.6 ju.g./ 
Effects of intravenous infusions of dopamine and norepivephrine on the bravhial arterial iiressure of a normal suhject.
ICg./min. and cardiac output increased by 40 per cent. Calculated peripheral resistance decreased in each patient.
OTHER OBSERVATIONS
"When dopamine and norepinephrine were administered to seven subjects in doses calculated to produce a systolic blood pressure increment of 25 mm. Jig, it was found that dopamine was 1/25 to l/5fi as active as norepinephrine.
The effects of dopamine infusions on blood glucose levels in six normal subjects are shown in table 2. There were relatively small but consistent increments in blood glucose levels in each subject during the dopamine infusions.
Adverse side effects did not occur with the dopamine infusions. The only subjective symptom described by the subjects was awareness of increased cardiac activity.
Discussion
In 1942, Holtz, Credner, and Koepp, 4 using bioassay, reported that dopamine was present in the urine of normal subjects. In 1951, von Euler and his associates 14 demonstrated the presence of the amine by chromatographic techniques and subsequently reported 15 that it is the predominant catecholamine excreted in the urine. A physiological role for dopamine, apart from being the precursor of norepinephrine, however, has not been demonstrated. Recently, Bertler. and Rosengren 1 " reported that the distribution of dopamine in mammalian brain, including that of man, is markedly different from that of norepinephrine, suggesting a possible role of the aini NE in brain function. These investigators observed that dopamine is present in high concentrations in the caudate nucleus and putamen, whereas norepinephrine is found in highest concentration in the hypothalamus.
Pharmacological studies have shown that dopamine resembles norepinephrine and epinephrine in that it increases heart contractile force, blood pressure, 5 and cardiac. output 0 of the anesthetized dog, and cardiac output of the heart-lung preparation of the cat. 3 Dopamine also raises blood pressure in the cat, 2 ' 4 but unlike the other catecholamines, it is a depressor in the guinea pig and rabbit. 4 The basis for such species differences is unknown.
Dopamine is a better substrate for monaniine oxidase than are norepinephrine and epinephrine, 17 which are considered to be preferentially metabolized by O-methyl transferase.- 18 Presumably because of this differ- The results of the present study indicate (hat the predominant cardiovascular effect of dopamine in man is an increase in stroke volume with a decrease or little change in peripheral resistance. In these ways, dopamine resembles epinephrine. However, the tachycardia frequently observed with the latter amine 10 was not seen with dopamine. The effects of dopamine were strikingly different from norepinephrine 1 " which markedly increases peripheral resistance with resultant reflex bradycardia. It has recently been demonstrated, 20 by means of the strain-gauge arch technique during cardiac surgery, that: epinephrine and norepinephrine produce similar increments in heart contractile force in man. On the basis of these results, differences in cardiac output produced by epinephrine and norepinephrine were related to differences in the effects of these eatecholamines on peripheral resistance. It is probable that the variation in the cardiovascular effects of dopamine and the other catecholamines would be related similarly to differences in peripheral, rather than to direct cardiac actions.
Effects of Dopuviine on Blood Glucose Leoels in Normal Subjects
The relatively minor increments in blood glucose levels which followed dopamine in-fusions are in marked contrast to the pronounced hyperglycemia produced by epinephrine and more closely resemble the effects of norepinephrine. 21 Preliminary studies 22 have shown that dopamine does not elevate plasma levels of unesterified fatty acids as do epinephrine and norepinephrine when the amines are administered in equipressor doses to normal subjects. These studies indicate that the presence of a /8-OII group in catecholamines not only increases cardiovascular potency, but increases metabolic actions to an even greater extent.
Dopamine was recently detected for the first time in plasma in a patient with malignant sympathicogonioma. 2:i There was insufficient information, however, to relate the clinical symptoms in this patient to dopamine blood levels. Since dopamine is only 1/25 to 1/50 as potent as norepinephrine in raising blood pressure in man, it seems unlikely that significant effects on the cardiovascular system would be produced unless extremely large amounts Avere involved.
Preliminary observations in this laboratory have shown that intravenous infusions of dopamine can increase the cardiac output of patients whose output does not increase appreciably Avith near maximally tolerated exercise. Such findings suggest the possible usefulness of dopamiue in patients in whom it is desirable to increase cardiac output without increasing peripheral resistance nor altering the metabolic state.
Summary
Dopamine, the biochemical precursor of norepinephrine, was infused intravenously into 11 normal subjects and 2 patients. Kesults of hemodynamic studies in 6 normal subjects indicated that dopamine increased cardiac output and stroke volume in all subjects. Arterial pressure also increased in all subjects with a predominant systolic pressure increment. Calculated vascular resistance decreased in 5 subjects and did not change in the other subject. Changes in heart rate were of small magnitude and were inconstant in direction. Left atrial pressure did not change in 2 patients at a time when substantial increments in cardiac output were produced by dopamine. Comparison of the doses of dopamine and norepinephrine calculated to produce equivalent increments in systolic pressure indicated that dopamine was 1/25 to 1/56 as potent as norepinephrine in this respect. Infusions of dopamine produced relatively small but consistent increments in blood glucose levels. It is concluded that the pharmacological actions of dopamine in man are different from those of epinephrine and norepinephrine. Because of its distinctive properties, dopamine may be useful in the treatment of patients with inadequate cardiac output.
